NCT06008223View on ClinicalTrials.gov

Clinical Analysis of Vitamin B6 in Sepsis

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions
SepsisVitamin B6Kidney InjuryInflammatory ResponseOxidative Stress Response
Interventions
DRUG

vitamin B6

The Patients in experimental group were given vitamin B6 injection 300mg/d (100mg/2ml× 3) intravenous injection.

DRUG

0.9% sodium chloride solution

That in control group were injected with 0.9% sodium chloride solution 6 ml intravenously.

Trial Locations (1)

313000

Wen-Ming Feng, Huzhou

All Listed Sponsors
lead

The First People's Hospital of Huzhou

OTHER

NCT06008223 - Clinical Analysis of Vitamin B6 in Sepsis | Biotech Hunter | Biotech Hunter